Luis Vitetta

Luis Vitetta is an Adjunct Professor at the Sydney School of Pharmacy, Faculty of Medicine and Health, University of Sydney. His research focuses on clinical epidemiology, human microbiome, and probiotics/prebiotics in relation to mood disorders and cellular redox systems.

Research Highlights:

• Lead trials on probiotic interventions for depression and metabolic disorders
• Pioneering cannabinoid delivery systems for cancer pain via NanoCelle™ technology
• Key work on gut-brain/lung/liver axes in non-communicable diseases
• Developed synbiotic formulations for bone loss and gastrointestinal health

Publication Trends reveal consistent output in microbiome, psychobiotics, cannabinoid pharmacokinetics, and epigenetic modulation across 2025-2014. His 15 most recent papers emphasize gut-brain axis, nano-drug delivery, and microbial metabolite impacts on chronic diseases.

Honors & Editorial Roles:

• Multiple journal editorial board memberships (2008-present)
• Scientific Advisory Board appointments
• Regular conference participation in nanotechnology and microbiome research

Academic Contributions include mentoring RHD students like Talia Palacios Campana, leading clinical trials on probiotics for diabetes, and publishing extensively in Frontiers, Microorganisms, and Pharmaceuticals.